Health: China should not be a test of the new drug supervision "lowland"

Wu jie (doctor)

Source: health

        Recently, the famous folk science organization "science squirrel will" members, Harbin doctor LiQingChen published articles to question the anti-aging academy of medical sciences, "be covered with a coat of science" foreign liar ", the establishment in China of Chinese web page, there are many false propaganda. Saying, the agency has deceive Chinese patients as "mouse" disrelish. (February 2, "the Beijing morning paper")

        "We Chinese showbiz are collective patched up calcium, he sent one step, haven't had time for you American entertainment industry calcium..." , the film "big shots" fu biao had in the American Taylor "funeral" on performance, and indeed classics. However, the film played, never want to still really score a lucky hit, became a fact. This is not, can cure cancer drugs, even the American people are still in not, but Chinese patients can worm, enjoy in advance. Compared with the film "calcium in advance," the reality of "early cancer" and really come more to the force.

        However, the above can cure cancer drugs, in fact is the Po JinSiJi invented by dr drug "an antineoplastic ketone". Now that is American invention of the drug, why not let the americans a tun, instead of the first WaiRenTian water flow for Chinese people benefit, I'm afraid I can't the whole return to international spirit. The situation really is, in the United States national cancer institute web site shows, "an antineoplastic ketone" at present only in phase ii clinical trial, still can't really used to treat cancer patients listed. Then, a second phase of clinical trial, not through the federal food and drug administration (FDA) authentication of the drug, why can't wait landmarks, came to China and became a cure for cancer can be "cancer drug god"?

        Undeniably, "the United States anti-aging academy of medical sciences," the name, does seem rather high-end and authority, under the banner in the promotion of a not listed of cancer drug approval, and to seek the cancer patients desperately as propaganda target, also really has MiHuoXing. However, since any drug only through three phase of clinical test before being allowed to the market, and not through the state food and drug administration of authentication import "an antineoplastic ketone," why their pitch to the Chinese cancer patients?

        In fact, China's first to patients with "cancer god medicine" back, in fact there powerful interest drive. For American medicine research and development institutions and pharmaceutical factory for, a day earlier through the FDA approval of the market, the profit is surprising. However, every new drug always after a certain stage of the clinical trials will put into use, the FDA for new drug approval process and the requirements of clinical trial data and all the more rigid; At the same time, because of the citizens' consciousness of rights is stronger, the concerns of the risk for new drugs that most americans don't want to become a drug test product; Plus a large number of special medical claims lawsuit play a lawyer, once the new drug test out the problems, and face will be astronomical claim amount. And in some developing countries, local patients is easy to persuade act as test object, because the local medical level is low, behind and expensive drugs, patients and lack of necessary safety consciousness, many people take part in new drug test, still think that accepted the "the best treatment". So, no matter accelerate new drug to market progress, or avoid test risk and lower the cost of consideration, foreign medicine enterprises to clinical trials of new drug transferred overseas, it is not an accident.

        This, actually have the data for card, in 2008 alone, the federal food and drug administration (FDA) received an nda report, 80% are in other countries the data from the test. In fact, even in the United States of China medical students and researchers also already involved in the overseas research and development, the chain of domestic test. Because have overseas status, biological medicine research and development is quite have the potential of the emerging industry in China and many places not only to this kind of project favour have add, even an additional investment, help clear the policy barriers is natural is self-evident. From this perspective, let the Chinese to cure cancer "an antineoplastic ketone," obviously won't be alone.

        Of course, only benefit drive, but not enough to make Chinese patients become "mice planning", the provisions of the new drug test domestic not strictly, drug use regulatory loose, and litigation risk low, no doubt, for "god anti-cancer drugs" provides the favour. Have something called "water flows downwards," regulatory loose, natural also form new drug test of low cost "lowland", only, the low cost, never is life in patients with a high risk of local health is cost.